Navigation Links
Panel blasts federal nanotech risk research strategy

Washington, DC A National Research Council (NRC) committee today issued a highly critical report describing serious shortfalls in the Bush administration's strategy to better understand the environment, health and safety (EHS) risks of nanotechnology and to effectively manage those potential risks.

The report, Review of the Federal Strategy to Address Environmental, Health, and Safety Research Needs for Engineered Nanoscale Materials, calls for a significantly revamped national strategic plan that will minimize potential risks so that innovation will flourish and society will reap nanotechnology's benefits.

Project on Emerging Nanotechnologies (PEN) Director David Rejeski maintains the "lessons learned" in the NRC report offer a silver lining that will help guide the administration of President-elect Barack Obama.

"It is disappointing that the Bush administration did not listen to PEN experts and repeated calls from nanotech industry and congressional leaders from both parties for an improved and revamped risk research plan for nanotechnology. Their delay has hurt investor and consumer confidence. It has gambled with public health and safety. It has jeopardized the $14 billion investment governments and private industry have made in this technology and its great promise for huge advancements in health care, energy and manufacturing. But I am encouraged that the NRC assessment will provide a roadmap for the next administration to make up for this lost time. It's time to get the job done and to get it done right," says Rejeski.

The risk research plan developed under the National Nanotechnology Initiative (NNI) has been widely criticized by consumer groups, chemical industry representatives and congressional lawmakers from both major parties as lacking a clear vision and the resources necessary to improve understanding of the potential risks posed by nanomaterials.

The new NRC report, written by a highly regarded team of top U.S. experts, echoes PEN experts' statements, analysis and research since 2005. PEN's work has extensively documented the need for a greatly improved government risk research strategy, more transparency and priority-setting in federal risk research funding, and a new mechanism for coordinating research.

The NRC document states that the NNI strategy "contains conflicting statements about the use of fiscal year 2006 research projects to evaluate research needs."

PEN experts have repeatedly stated that the risk-relevant research investment by the federal government was far less than the figures cited by the Bush administration. Most recently, PEN staff also developed federal risk-research funding options for moving forward (see:

The new NRC report also echoes PEN's calls for an improved mechanism for conducting research. As many as 18 federal agencies -- including the Defense Department, the Environmental Protection Agency and the Food and Drug Administration -- are under the umbrella of the NNI's environment and health implications working group, making coordinating research a challenging task.

PEN testimony before the House Committee on Science and Technology in both 2007 and 2008 provided detailed recommendations for a new mechanism for organizing federal nanotechnology research that would improve coordination among agencies. The principal recommendation is to replace the current bottom-up collection of individual agency research agendas and budgets with a top-down, highly focused and fully-funded strategy that addresses the risk research priorities of a rapidly commercializing new technology.

"The NRC report explicitly says that the federal plan 'does not have the essential elements of a research strategy,'" Rejeski says. "That is if nothing else a clear sign that it is time for a new start."


Contact: Colin Finan
Project on Emerging Nanotechnologies

Related biology technology :

1. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2008 Healthcare Conference
2. TorreyPines Therapeutics Enters into Agreement to Reduce Royalty Rates and Delay Clinical Milestone Payments Due to Eli Lilly for NGX426 and Tezampanel
3. Bradmer sponsors physician panel to raise awareness of brain cancer treatments
4. TorreyPines Therapeutics Begins Dosing in a Phase I Multiple Dose Clinical Trial of NGX426, Oral Prodrug of Tezampanel
5. Endovascular Forum Inc.s President to Participate in Health 2.0 Northeast Panel
6. TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
7. Vermillion Announces Receipt of NASDAQ Panel Decision
8. Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit
9. Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri
10. Arbitration Panel Issues Ruling in Distribution Dispute
11. TorreyPines Therapeutics to Present Tezampanel Phase IIb Clinical Data for Acute Migraine at 50th Annual Scientific Meeting of the American Headache Society
Post Your Comments:
(Date:10/9/2015)... Oct. 9, 2015  Pulmatrix, Inc., (NASDAQ: PULM ) ... investor conferences. th Annual BIO Investor ... (2:00 pm EDT). --> th Annual ... am PDT (2:00 pm EDT). --> Pulmatrix ... Growth Stock Conference on Thursday, October 15, 2015 at 8:30 ...
(Date:10/9/2015)... ... October 09, 2015 , ... Leading microbial genomics startup uBiome today ... understand the relationship between weight management and the microbiome. The study uses the ResearchKit ... using an iPhone app. , The uBiome app is available as a free download ...
(Date:10/8/2015)... Fla. , Oct. 8, 2015   Intrexon ... synthetic biology, today announced the appointment of Joseph ... Environment Sector, succeeding Nir Nimrodi who continues ... Vaillancourt will direct Intrexon,s endeavors to generate sustainable, biologically ... America , where he held a variety of ...
(Date:10/8/2015)... , Oct. 8, 2015  Genetic testing for mutations ... the identification of more couples at risk of having ... presented today at the 2015 American Society of Human ... in Baltimore, Maryland . The study ... (NYSE: DGX ) are presenting at the conference ...
Breaking Biology Technology:
... (a subsidiary of Elan Corporation, plc) ( ELN) ("Elan") to acquire the analgesic therapy, PRIALT(R) (ziconotide intrathecal infusion). , ... , , ... ... ...
... ... Be Discussed and Demonstrated at Philadelphia Conference , ... Chicago, IL (PRWEB) March 11, 2010 -- ClearTrial, the ... panel discussion which includes pharmaceutical analysts from Deutsche Bank and Cowen & Company at ...
... TORONTO , March 11 /PRNewswire/ - Trillium Therapeutics ... announced that it has entered into two definitive license agreements ... Children (SickKids) in Toronto, Ontario , granting Trillium exclusive ... of hematopoietic stem cell transplantation and cancer. , ...
Cached Biology Technology:
(Date:10/7/2015)... Sweden , October 8, 2015 ... the revenues for Fingerprint Cards (FPC) during third quarter 2015 ... revenue guidance of around 860 MSEK that was communicated 20 ... Considering a further strengthened delivery capacity and a continued growing ... quarter 2015 is estimated to be higher than during the ...
(Date:10/6/2015)... LAKE CITY , Oct. 6, 2015 ... company, announced today that it has signed a contract ... monitoring services across the full range of sentences under ... Group,s President of the Americas. "This contract with the ... region of the US and advances our position as ...
(Date:10/5/2015)... ) releases the following ... NXTD ), a biometric authentication company focused on the ... ) releases the following market and company update ... authentication company focused on the growing mobile commerce market. ... ) releases the following market and company update ...
Breaking Biology News(10 mins):
... the most commonly cultivated cacao plant in the world ... this week. Researchers have utilised high quality DNA sequences to ... markers that can lead to higher yielding cocoa plants that still ... the cacao tree ( Theobroma cacao L. ...
... species, according to a new study led by Woods ... published in the journal PLOS ONE . Because ... may have far-reaching effects on the ocean environment and ... the center of the ocean ecosystemnearly all animals are ...
... insecurity increases the risk of death among injection drug ... life-prolonging antiretroviral therapy (ART), according to a new study ... the peer-reviewed science journal, PLoS One , examines ... among injection drug users. Food insecurity is defined by ...
Cached Biology News:
... Software reads and processes raw ... microarray data for analysis. ... one 2-year license for Feature ... , * one CD-ROM ...
... imported for data analysis , Automatic grid, subgrid ... template assignment , ... Extensive background and signal options to optimize, ... results , ...
... DNA Gel Stain combo offers these benefits: ... products separately Offers a ... Eliminates risks to yourself, the environment ... from 100 bp to >30 kb. UltraPure Agarose is ...
... stocks contained in standard 96-well microtiter plates. ... approximately 5,000 clones per plate. After positive ... the corresponding subplate is screened with a ... well(s). Cells from a positive well are ...
Biology Products: